Cannabis, or Marijuana is a controlled substance which is illegal to possess, use, or distribute in New York State. Medical Marijuana, however, is legal in New York State although adult recreational use remains prohibitied. Under the federal Controlled Substances Act of 1970, marijuana was placed in Schedule I, which defines the substance as having a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision.
Jacobowitz and Gubits attorneys are ready to help New York businesses entering the cannabis industry by providing legal direction in the areas of:
- Government Regulations and Compliance
- Licensing and Permitting
- New York State Licensing for Cultivation and Dispensaries
- Business Counseling and Litigation
- Intellectual Property – Trademarks and Copywriting
- Labor and Employment
- Real Estate
- Land Use and Zoning
- ADA Compliance
- Tax Advice
Many of our attorneys have received the necessary continuing educational training to provide you with the guidance necessary to follow the federal and state laws governing cannabis law.
A Marijuana Update in New York 12/13/18
Gov. Andrew Cuomo will soon unveil a plan to legalize recreational marijuana in the state, his office announced on December 11, 2018.
“The goal of this administration is to create a model program for regulated adult-use cannabis — and the best way to do that is to ensure our final proposal captures the views of everyday New Yorkers,” said Cuomo spokesman Tyrone Stevens. The aide added that the proposal would come early next year, when Democrats in the state will have control of every branch of New York’s government.
The odds are good that New York State will legalize marijuana in 2019, possibly as soon as the end of March. But what the system will look like — including who’ll be able to sell pot, where it can be smoked, and what will be done with taxes on sales — is largely in the hands of Gov. Andrew Cuomo, who has remained mum about his plans.
If you are interested in LEGALLY selling, or buying, marijuana within New York State, keep watching this space. Jacobowitz and Gubits will be in the forefront of helping those who want to participate in this exciting new endeavor.
Listening Session 10/1/18
Allison Cappella, associate attorney at Jacobowitz & Gubits, attended Governor Cuomo’s regulated marijuana listening session for the Mid-Hudson region in Newburgh on 10/1/18. The New York State Senate and Assembly are expected to take up regulated marijuana legislation in the 2019 session. The Governor is holding 19 listening sessions throughout New York because “[c]ommunity input is critical as we work to draft balanced and comprehensive legislation on a regulated marijuana program in New York,” Gov. Andrew Cuomo said. The hope is that New York develops a model program when and if regulated marijuana is legalized. The Newburgh session had approximately 100 people in attendance. The crowd drew supporters and opponents of the legalization of regulated marijuana. Opponents cited the increase of marijuana related driving deaths and injuries in Colorado after marijuana was legalized. They also cited studies that purport that smoking marijuana at a young age could affect cognitive brain functions. Opponents included addiction counsellors, nurses, parents, and governmental health officials from Dutchess County, Rockland County, and other Hudson Valley locations. Supporters included sufferers of chronic pain, including multiple sclerosis, lupus, and PTSD. These people testified to the great pain relief they experienced from smoking marijuana and their ability to stop taking opioid-based pain medication. Other supporters included organic farmers lobbying against a few large farms winning all of the state’s regulated marijuana licenses and ultimately controlling the market. The organic farmers not only testified in support of small family farmers being able to grow regulated marijuana as a lucrative alternative to other farming, but also that the state’s regulated marijuana program should require that all marijuana be grown organically, which is not done in other states. If passed, the effects of regulated marijuana in New York remain to be seen.
Governor Cuomo Actions
In January 2018, Governor Cuomo called for an assessment of the possible impact of regulating marijuana in New York State. NYS agencies evaluated the health, public safety, and economic impact of legalizing marijuana. A summary of the report has been provided by Robert M. Lefland and you can view it here. This 74-page assessment concludes that the benefits of legalization outweigh potential risks. It suggests that NYS could raise nearly $700 million in tax revenue from this drug and that legalization won’t significantly increase rates of marijuana use by adults and teens. The report suggests that legalizing marijuana could both reduce opioid dependency while eliminating criminal penalties that disproportionately impact minorities. This report was released in July, 2018.
In August, Governor Cuomo took another step toward legalizing marijuana in New York State, announcing the formation of a 20-person work group to draft legislation allowing for recreational use by adults.
Marijuana in New York State
Staying current is important in all areas of law. The legal use of marijuana in New York State is undergoing intense scrutiny and much is changing. There is, however, one aspect which remains crystal clear, if not subject to change at almost any moment.
The recreational use of marijuana, as of this writing August 10, 2018, remains illegal.
Medical use, however, has changed. In July 2014, Governor Andrew M. Cuomo and the New York State Legislature enacted the Compassionate Care Act to provide a comprehensive, safe and effective medical marijuana program that meets the needs of New Yorkers. This bill comprehensively regulates the manufacture, sale and use of medical marijuana. It attempts to strike the right balance between potentially relieving the pain and suffering of those in desperate need of a treatment and protecting the public against risks to its health and safety. The balance is maintained by granting discretion to physicians to prescribe in accordance with regulatory requirements and medical norms, empowering the Department of Health to oversee the regimen of medical marijuana usage and leaving to the Governor, the final say in seeing that the public’s safety and health are protected by authorizing him to discontinue the program, in whole or in part, should risks to the public so warrant.
Department of Health
The Department of Health has stated that as of July 10, 2018, there are 62,256 certified patients and 1,735 registered practitioners participating in the program.
On December 8, 2017 The New York State Department of Health announced that it was filing regulations for adoption that will improve the state’s Medical Marijuana Program for patients, practitioners and registered organizations. These regulations, which went into effect on December 27, 2017, allow for the sale of additional medical marijuana products, an improved experience for patients and visitors at dispensing facilities and the ability for the Department to approve new courses that will allow prospective practitioners to complete their training in a shorter amount of time.
Under the new regulations, registered organizations (ROs) are allowed to manufacture and distribute additional products including topicals such as ointments, lotions and patches; solid and semi-solid products, including chewable and effervescent tablets and lozenges; and certain non-smokable forms of ground plant material. All products are subject to rigorous testing, and the Department reserves the right to exclude inappropriate products or those which pose a threat to public health.
Other recent enhancements to New York’s Medical Marijuana Program include authorizing five additional registered organizations to manufacture and dispense medical marijuana, adding post-traumatic stress disorder and chronic pain as qualifying conditions, empowering nurse practitioners and physician assistants to certify patients and permitting home delivery.